114 related articles for article (PubMed ID: 38415859)
1. Antibody targeting of surface P-selectin glycoprotein ligand 1 leads to lymphoma apoptosis and tumorigenesis inhibition.
Pereira JL; Ferreira F; Dos Santos NR
Hematol Oncol; 2024 Mar; 42(2):e3257. PubMed ID: 38415859
[TBL] [Abstract][Full Text] [Related]
2. A novel P-selectin glycoprotein ligand-1 monoclonal antibody recognizes an epitope within the tyrosine sulfate motif of human PSGL-1 and blocks recognition of both P- and L-selectin.
Snapp KR; Ding H; Atkins K; Warnke R; Luscinskas FW; Kansas GS
Blood; 1998 Jan; 91(1):154-64. PubMed ID: 9414280
[TBL] [Abstract][Full Text] [Related]
3. P-selectin glycoprotein ligand 1 promotes T cell lymphoma development and dissemination.
Pereira JL; Cavaco P; da Silva RC; Pacheco-Leyva I; Mereiter S; Pinto R; Reis CA; Dos Santos NR
Transl Oncol; 2021 Aug; 14(8):101125. PubMed ID: 34090013
[TBL] [Abstract][Full Text] [Related]
4. P-Selectin glycoprotein ligand 1 (PSGL-1) is expressed on platelets and can mediate platelet-endothelial interactions in vivo.
Frenette PS; Denis CV; Weiss L; Jurk K; Subbarao S; Kehrel B; Hartwig JH; Vestweber D; Wagner DD
J Exp Med; 2000 Apr; 191(8):1413-22. PubMed ID: 10770806
[TBL] [Abstract][Full Text] [Related]
5. The binding of T cell-expressed P-selectin glycoprotein ligand-1 to E- and P-selectin is differentially regulated.
Borges E; Pendl G; Eytner R; Steegmaier M; Zöllner O; Vestweber D
J Biol Chem; 1997 Nov; 272(45):28786-92. PubMed ID: 9353350
[TBL] [Abstract][Full Text] [Related]
6. L-selectin ligands expressed by human leukocytes are HECA-452 antibody-defined carbohydrate epitopes preferentially displayed by P-selectin glycoprotein ligand-1.
Tu L; Murphy PG; Li X; Tedder TF
J Immunol; 1999 Nov; 163(9):5070-8. PubMed ID: 10528213
[TBL] [Abstract][Full Text] [Related]
7. Visualization of P-selectin glycoprotein ligand-1 as a highly extended molecule and mapping of protein epitopes for monoclonal antibodies.
Li F; Erickson HP; James JA; Moore KL; Cummings RD; McEver RP
J Biol Chem; 1996 Mar; 271(11):6342-8. PubMed ID: 8626430
[TBL] [Abstract][Full Text] [Related]
8. P-selectin glycoprotein ligand-1 (PSGL-1) is a ligand for L-selectin in neutrophil aggregation.
Guyer DA; Moore KL; Lynam EB; Schammel CM; Rogelj S; McEver RP; Sklar LA
Blood; 1996 Oct; 88(7):2415-21. PubMed ID: 8839831
[TBL] [Abstract][Full Text] [Related]
9. Tonsillar B cells do not express PSGL-1, but a significant fraction displays the cutaneous lymphocyte antigen and exhibits effective E- and P-selectin ligand activity.
Armerding D; Fuhlbrigge RC; Kieffer JD; Kupper TS
Int Arch Allergy Immunol; 2001 Sep; 126(1):78-90. PubMed ID: 11641609
[TBL] [Abstract][Full Text] [Related]
10. A human colon carcinoma cell line exhibits adhesive interactions with P-selectin under fluid flow via a PSGL-1-independent mechanism.
Goetz DJ; Ding H; Atkinson WJ; Vachino G; Camphausen RT; Cumming DA; Luscinskas FW
Am J Pathol; 1996 Nov; 149(5):1661-73. PubMed ID: 8909255
[TBL] [Abstract][Full Text] [Related]
11. Rolling of Th1 cells via P-selectin glycoprotein ligand-1 stimulates LFA-1-mediated cell binding to ICAM-1.
Atarashi K; Hirata T; Matsumoto M; Kanemitsu N; Miyasaka M
J Immunol; 2005 Feb; 174(3):1424-32. PubMed ID: 15661900
[TBL] [Abstract][Full Text] [Related]
12. Engagement of P-selectin glycoprotein ligand-1 enhances tyrosine phosphorylation and activates mitogen-activated protein kinases in human neutrophils.
Hidari KI; Weyrich AS; Zimmerman GA; McEver RP
J Biol Chem; 1997 Nov; 272(45):28750-6. PubMed ID: 9353345
[TBL] [Abstract][Full Text] [Related]
13. P-selectin glycoprotein ligand-1 (PSGL-1) on T helper 1 but not on T helper 2 cells binds to P-selectin and supports migration into inflamed skin.
Borges E; Tietz W; Steegmaier M; Moll T; Hallmann R; Hamann A; Vestweber D
J Exp Med; 1997 Feb; 185(3):573-8. PubMed ID: 9053457
[TBL] [Abstract][Full Text] [Related]
14. The metastatic T-cell hybridoma antigen/P-selectin glycoprotein ligand 1 is required for hematogenous metastasis of lymphomas.
Raes G; Ghassabeh GH; Brys L; Mpofu N; Verschueren H; Vanhecke D; De Baetselier P
Int J Cancer; 2007 Dec; 121(12):2646-52. PubMed ID: 17721882
[TBL] [Abstract][Full Text] [Related]
15. Functional characterization of L-selectin ligands on human neutrophils and leukemia cell lines: evidence for mucinlike ligand activity distinct from P-selectin glycoprotein ligand-1.
Ramos CL; Smith MJ; Snapp KR; Kansas GS; Stickney GW; Ley K; Lawrence MB
Blood; 1998 Feb; 91(3):1067-75. PubMed ID: 9446670
[TBL] [Abstract][Full Text] [Related]
16. Neutrophils use both shared and distinct mechanisms to adhere to selectins under static and flow conditions.
Patel KD; Moore KL; Nollert MU; McEver RP
J Clin Invest; 1995 Oct; 96(4):1887-96. PubMed ID: 7560080
[TBL] [Abstract][Full Text] [Related]
17. Distinct sulfation requirements of selectins disclosed using cells that support rolling mediated by all three selectins under shear flow. L-selectin prefers carbohydrate 6-sulfation totyrosine sulfation, whereas p-selectin does not.
Kanamori A; Kojima N; Uchimura K; Muramatsu T; Tamatani T; Berndt MC; Kansas GS; Kannagi R
J Biol Chem; 2002 Sep; 277(36):32578-86. PubMed ID: 12068018
[TBL] [Abstract][Full Text] [Related]
18. A functional epitope on P-selectin that supports binding of P-selectin to P-selectin glycoprotein ligand-1 but not to sialyl Lewis X oligosaccharides.
Hirose M; Kawashima H; Miyasaka M
Int Immunol; 1998 May; 10(5):639-49. PubMed ID: 9645612
[TBL] [Abstract][Full Text] [Related]
19. Important contributions of P-selectin glycoprotein ligand-1-mediated secondary capture to human monocyte adhesion to P-selectin, E-selectin, and TNF-alpha-activated endothelium under flow in vitro.
Lim YC; Snapp K; Kansas GS; Camphausen R; Ding H; Luscinskas FW
J Immunol; 1998 Sep; 161(5):2501-8. PubMed ID: 9725249
[TBL] [Abstract][Full Text] [Related]
20. P-selectin glycoprotein ligand-1 contributes to wound healing predominantly as a p-selectin ligand and partly as an e-selectin ligand.
Tomita H; Iwata Y; Ogawa F; Komura K; Shimizu K; Yoshizaki A; Hara T; Muroi E; Yanaba K; Bae S; Takenaka M; Hasegawa M; Fujimoto M; Sato S
J Invest Dermatol; 2009 Aug; 129(8):2059-67. PubMed ID: 19177138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
